Factor 7 helped Medical Interface Solutions secure key grants, strengthen its regulatory and commercial strategy, and access expert resources to drive funding readiness and market growth.

Factor 7 helped SweetBio refine its strategy, secure investors, and launch a scalable sales model—driving new revenue, stronger market positioning, and sustainable growth.

Dilon Technologies needed support to identify an experienced R&D and engineering leader to guide the company into its next phase of growth. In addition, they required project management expertise to bring structure, alignment, and timely execution to key initiatives.

Factor 7 helped EndoEvolve secure funding opportunities, optimize manufacturing and regulatory strategies, and build key industry relationships to accelerate their path to commercialization.

Factor 7 streamlined go-to-market efforts by targeting high-use neurology clinics, restructuring sales, and improving onboarding to boost adoption and reduce churn.